Blood bank reagents OY3
Ended Awarded Last action
- Contract number
- 36C25524N0268
- Awardee
-
Alba Bioscience, Inc. UEI V6KNKL6BDHL7
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $34,932
Award facts
- Contract value 100% obligated
- $34,931.52 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Chicago, IL 60607, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$398 | |
| Funding Only Action | -$1,780 | |
| Other Administrative Action | -$575 | |
| Funding Only Action | -$2,982 | |
| Funding Only Action | -$3,272 | |
| Funding Only Action | -$580 | |
| Funding Only Action | -$4,415 | |
| Funding Only Action | $607 | |
| Funding Only Action | $229 | |
| Original award | $48,097 |
About this award
Alba Bioscience, Inc., a Chicago-based supplier of immunohematology reagents and blood banking diagnostics, received a modification worth $1,779.99 under a Blanket Purchase Agreement Call with Veterans Integrated Service Network 15. The modification, issued on June 1, 2024, for purchase order #589C40149, brings the contract ceiling to $34,931.52 and extends the ultimate completion date to May 31, 2025. This task order falls under Alba Bioscience's broader BPA with the VA, valued at $199,671.75 and awarded on the GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract is undesignated and procured on a competitive, firm fixed-price basis, reflecting the specialized nature of Alba Bioscience's offerings in the federal healthcare marketplace.
The supplies being delivered under this modification include blood bank reagents critical to transfusion services and diagnostic testing operations at VA medical facilities. Alba Bioscience's product portfolio encompasses monoclonal antibodies targeting various blood group antigens, antibody identification and screening panels, quality control kits, and additive solutions—all essential for blood typing, compatibility testing, and immunohematology screening. The modification represents continued procurement activity under the larger parent BPA, which enables multiple Veterans Integrated Service Networks across the VA's integrated healthcare system to efficiently order blood banking supplies through streamlined task order processes to support transfusion medicine operations nationwide.
Quick answers
Who was awarded contract 36C25524N0268?
36C25524N0268 was awarded to Alba Bioscience, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2024.
How much is contract 36C25524N0268 worth?
The government has obligated $34,932 on 36C25524N0268.
Is contract 36C25524N0268 an order under another contract?
Yes. 36C25524N0268 is a BPA call under V797P2050D-36C25520A0034, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 36C25524N0268 competed?
The extent of competition for 36C25524N0268 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award